Mobile

A 4 week, randomized, vehicle-controlled, multicenter evaluation of the efficacy and safety of 1% pimecrolimus cream in adult patients with perioral dermatitis followed by a 8 week treatment free obse...

Update Il y a 4 ans
Reference: EUCTR2005-002058-23

A 4 week, randomized, vehicle-controlled, multicenter evaluation of the efficacy and safety of 1% pimecrolimus cream in adult patients with perioral dermatitis followed by a 8 week treatment free observation phase in responders

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To confirm the efficacy of pimecrolimus cream 1% in patients with perioral dermatitis, by testing the hypothesis that pimecrolimus cream 1% is superior in the mean reduction of the PODSI score (Perioral Dermatitis Severity Index) at weeks 1, 2 and 4 of treatment compared to its vehicle.

Inclusion criteria

  • perioral dermatitis

Links